Trials / Completed
CompletedNCT01350869
Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry)
Evaluation of Effectiveness and Safety of Everolimus-Eluting Stents in Routine Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Seung-Jung Park · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate effectiveness and safety of everolimus-eluting stents (XIENCE, Abbott) in the "real world" daily practice as compared with first-generation drug-eluting stents (sirolimus-eluting stents).
Detailed description
This study is a non-randomized, open-label registry to compare the efficacy and safety of everolimus-eluting stents versus sirolimus-eluting stents in patients with coronary artery disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Xience | Patients with Xience |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2011-12-01
- Completion
- 2014-06-01
- First posted
- 2011-05-10
- Last updated
- 2015-11-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01350869. Inclusion in this directory is not an endorsement.